Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2012
Financial Results and Host Conference Call on February 27, 2013
POINT RICHMOND, Calif., Feb. 21, 2013
POINT RICHMOND, Calif., Feb. 21, 2013 /PRNewswire/ -- Transcept
Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company
focused on the development and commercialization of proprietary products that
address important therapeutic needs in the field of neuroscience, today
announced that the company will host a conference call on Wednesday, February
27, 2013, at 4:30 p.m. Eastern Time to discuss its fourth quarter and full
year 2012 financial results. The conference call will follow the release of
the Transcept fourth quarter and full year 2012 financial results after the
close of market that day.
Conference Call Information
Date: Wednesday, February 27, 2013
Time: 4:30 p.m. ET
Dial-in (U.S.): 877-638-4558
Dial-in (International): 914-495-8537
A simultaneous webcast of the conference call will be available on the
Investors section of the Transcept website at www.transcept.com. A replay of
this webcast will be available on the website shortly after the conclusion of
the call through March 31, 2013.
Transcept Pharmaceuticals, Inc.is a specialty pharmaceutical company focused
on the development and commercialization of proprietary products that address
important therapeutic needs in the field of neuroscience. Intermezzo®
(zolpidem tartrate) sublingual tablet C-IV is the firstFDAapproved Transcept
product.PurduePharma holds commercialization and development rights for
Intermezzo in the United States. For further information about Transcept,
please visit www.transcept.com. For information about Intermezzo, please visit
Transcept Pharmaceuticals, Inc.
Sr. Director, Corporate Communications
SOURCE Transcept Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.